Deblina Sarkar shares how nano-electronic implants could transform treatment for neurological diseases, with implications for women’s health.

Professor Deblina Sarkar, head of the Nano-Cybernetic Biotrek research group at the MIT Media Lab, spoke with hosts Carol Massar and David Gura on Bloomberg Businessweek Daily about her lab’s pioneering use of microscopic technology to address diseases that disproportionately affect women.

Her team has developed non-surgical nano-electronic devices that travel through body fluids, locate diseased brain regions, and deliver targeted electrical stimulation. These implants offer promising treatment options for conditions like Alzheimer’s, chronic pain, and terminal brain cancers such as Glioblastoma, DIPG—without the need for invasive brain surgery.

Demonstrated successfully in animal models, the technology is moving toward human clinical trials within the next three years. Sarkar’s work is part of the MIT Media Lab’s broader efforts in women’s health through programs like WHx, which seeks to close critical gaps in research, care, and innovation.